loadpatents
name:-0.020099878311157
name:-0.015907049179077
name:-0.0071520805358887
Schaeffer; Lauge Patent Filings

Schaeffer; Lauge

Patent Applications and Registrations

Patent applications and USPTO patent grants for Schaeffer; Lauge.The latest application filed is for "novel acylated insulin analogues and uses thereof".

Company Profile
4.18.15
  • Schaeffer; Lauge - Lyngby DK
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Novel Acylated Insulin Analogues and Uses Thereof
App 20210094999 - Olsen; Grith Skytte ;   et al.
2021-04-01
Acylated insulin analogues and uses thereof
Grant 10,919,949 - Olsen , et al. February 16, 2
2021-02-16
Novel Acylated Insulin Analogues and Uses Thereof
App 20190194285 - Olsen; Grith Skytte ;   et al.
2019-06-27
Amylin and calcitonin receptor agonist
Grant 10,174,082 - Kruse , et al. J
2019-01-08
Novel Amylin And Calcitonin Receptor Agonist
App 20170145059 - Kruse; Thomas ;   et al.
2017-05-25
Truncated GLP-1 derivatives and their therapeutical use
Grant 9,657,079 - Spetzler , et al. May 23, 2
2017-05-23
Amylin and calcitonin receptor agonist
Grant 9,593,149 - Kruse , et al. March 14, 2
2017-03-14
Double-acylated GLP-1 derivatives
Grant 9,556,250 - Garibay , et al. January 31, 2
2017-01-31
Novel Amylin And Calcitonin Receptor Agonist
App 20160272683 - Kruse; Thomas ;   et al.
2016-09-22
Glucagon-like peptide-1 derivatives and their pharmaceutical use
Grant 9,409,966 - Spetzler , et al. August 9, 2
2016-08-09
Peptides derivatized with A-B-C-D- and their therapeutical use
Grant 9,067,977 - Spetzler , et al. June 30, 2
2015-06-30
Amylin analogues and pharmaceutical compositions thereof
Grant 9,029,325 - Schaeffer , et al. May 12, 2
2015-05-12
Amylin analogs and pharmaceutical compositions thereof
Grant 9,023,789 - Dahl , et al. May 5, 2
2015-05-05
Acylated exendin-4 compounds
Grant 9,012,398 - Lau , et al. April 21, 2
2015-04-21
Glucagon-like Peptide-1 Derivatives And Their Pharmaceutical Use
App 20150025003 - Spetzler; Jane ;   et al.
2015-01-22
Truncated GLP-1 Derivatives and Their Therapeutical Use
App 20140296131 - Spetzler; Jane ;   et al.
2014-10-02
Polypeptides
Grant 8,741,836 - Schaeffer , et al. June 3, 2
2014-06-03
Polypeptides
Grant 8,722,849 - Schaeffer , et al. May 13, 2
2014-05-13
Polypeptides
App 20140087995 - Dahl; Kirsten ;   et al.
2014-03-27
Amylin Analogues And Pharmaceutical Compositions Thereof
App 20140018286 - Schaeffer; Lauge ;   et al.
2014-01-16
Peptides Derivatized with A-B-C-D- and their Therapeutical Use
App 20140011732 - Spetzler; Jane ;   et al.
2014-01-09
Amylin analogues and pharmaceutical compositions thereof
Grant 8,575,090 - Schaeffer , et al. November 5, 2
2013-11-05
Amylin analogues and pharmaceutical compositions thereof
Grant 8,575,091 - Dahl , et al. November 5, 2
2013-11-05
Polypeptides
App 20130281363 - Dahl; Kirsten ;   et al.
2013-10-24
Polypeptides
App 20130059770 - Schaeffer; Lauge ;   et al.
2013-03-07
Polypeptides
App 20130012427 - SCHAEFFER; LAUGE ;   et al.
2013-01-10
Polypeptides
App 20130005646 - Schaeffer; Lauge ;   et al.
2013-01-03
Acylated Exendin-4 Compounds
App 20120283170 - Lau; Jesper ;   et al.
2012-11-08

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed